PPARG and hepatocellular carcinoma: In many other studies PPARγ agonists induced apoptosis in bladder cancer [217], gastric carcinoma [133,218], lung cancer [219], esophageal adenocarcinoma [220], pancreatic cancer [221], hepatocellular carcinoma [222], neuroblastoma [223], melanoma [141,142], glioblastoma [224], leukemia [225], leiomyoma [226], mesothelioma [153], and colon carcinoma [227].